Viewing StudyNCT00340834



Ignite Creation Date: 2024-05-05 @ 4:55 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00340834
Status: COMPLETED
Last Update Posted: 2017-09-21
First Post: 2006-06-19

Brief Title: Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Multiple Sclerosis
Keywords:
Name View
Efficacy View
FTY720 View
Interferon View
RRMS View
Multiple Sclerosis View